Inventor · disambiguated record
Mladen Tomich
Also filed as: TOMICH MLADEN
7 granted patents·5 pending applications·32 citations·filing 2012–2025
83Inventor score
Top patents by PatentIndex Score
12 records- 0190US11203633B2Polynucleotides encoding antibodies or antigen binding fragments thereof that bind pseudomonas pervMEDIMMUNE LTD·Filed 2020·Granted Dec 21, 2021·2 cites·25 claims
- 0289US10844114B2Anti-Pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2019·Granted Nov 24, 2020·3 cites·21 claims
- 0389US9580509B2Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Feb 28, 2017·9 cites·18 claims
- 0487US10370436B2Anti-pseudomonas Psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2016·Granted Aug 6, 2019·5 cites·5 claims
- 0583US9403901B2Anti-pseudomonas Psl binding molecules and uses thereofDIGIANDOMENICO ANTONIO·Filed 2012·Granted Aug 2, 2016·9 cites·14 claims
- 0681US10597439B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LLC·Filed 2012·Granted Mar 24, 2020·4 cites·7 claims
- 0777US12428473B2Combination therapies using anti-pseudomonas PSL and PCRV binding moleculesMEDIMMUNE LTD·Filed 2021·Granted Sep 30, 2025·0 cites·20 claims
- 0872US2025243262A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LTD·Filed 2025·Application pending·0 cites
- 0969US2021130442A1Anti-pseudomonas psl binding molecules and uses thereofMEDIMMUNE LTD·Filed 2020·Application pending·0 cites
- 1048US2017114151A1Multispecific and multivalent binding proteins and uses thereofMEDIMMUNE LLC·Filed 2016·Application pending·0 cites
- 1145US2015284450A1Combination therapies using anti-pseudomonas psl and pcrv binding moleculesMEDIMMUNE LLC·Filed 2013·Application pending·0 cites
- 1236US2017183397A1Multi-specific anti-pseudomonas psl and pcrv binding molecules and uses thereofMEDIMMUNE LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mladen Tomich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →